J W Mier

Phase I evaluation of intravenous recombinant human interleukin 12 in patients with advanced malignancies.

Michael B. Atkins, Michael J. Robertson, Michael S. Gordon et al. · PubMed · 1997 · 590 citations

Medicine, Oncology, Pharmacology +15

Purification and some characteristics of human T-cell growth factor from phytohemagglutinin-stimulated lymphocyte-conditioned media.

J W Mier, Robert C. Gallo · Proceedings of the National Academy of Sciences · 1980 · 297 citations · Full text

Life Sciences, Biochemistry, Immunology +15

Phase I trial of twice-weekly intravenous interleukin 12 in patients with metastatic renal cell cancer or malignant melanoma: ability to maintain IFN-gamma induction is associated with clinical response.

Jared Gollob, J W Mier, Korina G. Veenstra et al. · PubMed · 2000 · 289 citations

Medicine, Oncology, Pharmacology +15

T-cell lines established from human T-lymphocytic neoplasias by direct response to T-cell growth factor.

Bernard J. Poiesz, Francis W. Ruscetti, J W Mier et al. · Proceedings of the National Academy of Sciences · 1980 · 287 citations · Full text

Life Sciences, Cell Biology, Oncology +14

Antiinflammatory properties of hepatic acute phase proteins: preferential induction of interleukin 1 (IL-1) receptor antagonist over IL-1 beta synthesis by human peripheral blood mononuclear cells.

Herbert Tilg, Edouard Vannier, Gloria Vachino et al. · The Journal of Experimental Medicine · 1993 · 259 citations · Full text

Life Sciences, Immunology, Pharmacology +13